EXOPHARM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0275 AUD | +10.00% |
|
-.--% | -.--% |
| 02-26 | Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| 2023 | Exopharm to Cut CEO Role Amid Cost Reductions | MT |
Performance
| 1 day | +10.00% | ||
| 1 year | -42.11% | ||
| 3 years | -98.57% | ||
| 5 years | -97.41% |
Volumes
marketsDaily volume
29 049
Estimated daily volume
29 049
Record volume 1
8 321 108
Record volume 2
5 444 500
Record volume 3
4 294 944
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
4 799 399
Capitalization (USD)
3 152 245
Net sales (AUD)
3 393 141
Net sales (USD)
2 228 615
Free-Float
24.71 %
Free-Float capitalization (AUD)
2 965 342
Free-Float capitalization (USD)
1 947 637
Highs and lows
1 year
0.01
0.04
3 years
0.011.94
5 years
0.012.50
10 years
0.012.50
Indicators
Moving average 5 days
0.01
Moving average 20 days
0.02
Moving average 50 days
0.02
Moving average 100 days
0.01
Price spread / (MMA5)
-62.18%
Price spread / (MMA20)
-13.09%
Price spread / (MMA50)
-12.00%
Price spread / (MMA100)
-64.73%
RSI 9 days
65.57
RSI 14 days
61.23
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +10.00% | -.--% | -.--% | -42.11% | 3.15M | ||
| +0.91% | +2.45% | +2.44% | +24.74% | 42.75B | ||
| -1.02% | +3.08% | +47.70% | -5.60% | 41.61B | ||
| +3.14% | +6.50% | +11.86% | -16.61% | 41.34B | ||
| +4.02% | +6.25% | -8.83% | +14.38% | 26.59B | ||
| -1.93% | +1.66% | +7.00% | +54.97% | 25.49B | ||
| +3.05% | +1.63% | -22.60% | -26.61% | 18.12B | ||
| +1.07% | +6.27% | +30.44% | +93.64% | 12.24B | ||
| +0.96% | -0.31% | -1.93% | +21.95% | 11.76B | ||
| +2.63% | +2.58% | +9.20% | +3.45% | 11B | ||
| +1.83% | +3.34% | -15.89% | -18.09% | 10.07B | ||
| +1.27% | +2.38% | -5.75% | -8.55% | 9.22B | ||
| +0.12% | +3.57% | +24.92% | -15.11% | 6.65B | ||
| +3.41% | +20.21% | +8.55% | -34.40% | 6.44B | ||
| +2.11% | +0.91% | +28.17% | +54.13% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +2.00% | +3.39% | +7.68% | +6.68% | ||
| Weighted average by Cap. | +1.32% | +3.94% | +10.19% | +9.77% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2023 | -81.67% | ||
| 2022 | -88.46% | ||
| 2021 | -8.77% | ||
| 2020 | +119.23% | ||
| 2019 | -52.73% | ||
| 2018 | +5.77% |
- Stock Market
- Equities
- EX1 Stock
- Quotes Exopharm Limited
